Last reviewed · How we verify

NCT05683275

Short and Long Term Effects of IASTM and ESWT Therapy in Individuals With Lateral Epicondylitis

Completed NA Last updated 14 March 2023
What this trial tests

NA trial testing IASTM in Lateral Epicondylitis in 45 participants. Completed in 7 March 2023.

Timeline
28 December 2022
Primary endpoint
7 March 2023
7 March 2023

Quick facts

Lead sponsorKTO Karatay University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment45
Start date28 December 2022
Primary completion7 March 2023
Estimated completion7 March 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

KTO Karatay University

Who can join

Adults 18 to 45, any sex, with Lateral Epicondylitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pain, decreased grip strength, and loss of function are observed in individuals with lateral epicondylitis. The aim of this study is to investigate the effects of ESWT and IASTM applications on pain, grip strength and function in individuals with lateral epicondylitis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of IASTM

Trials testing the same drug.

Other recruiting trials for Lateral Epicondylitis

Currently open trials in the same condition.

Other KTO Karatay University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05683275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing